Re: Anyone else on the trial S-222611?
Hi there
I asked when I was last in hospital what will happen with this drug, as its been very successful in our small cohort of women - 10 out of 11 responded, at least one complete remission and everyone else good partial responses. Its a phase1/2 I think. Was told they will collect all the data this year and decide whether to take forward - I am praying that they do asap as it is fantastic, and almost no side effects as so targeted.
I had previously filed on Xeloda, kadcyla and Herceptin hadn't really worked either, so things weren't looking good.
If I hear any more will let you know
Best wishes and hope things stay stable . Let me know if you get on MM302 and how that is, as Im always looking for the next drug.
Lesley
|